HER-2/neu oncogene amplification in breast cancer

被引：0
|
作者：
Depowski, PL
Brien, TP
Sheehan, CE
Muraca, PJ
Stylos, S
Johnson, RL
Ross, JS
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
[2] Berkshire Med Ctr, Pittsfield, MA USA
来源：
MODERN PATHOLOGY | 1998年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：18A / 18A
页数：1
相关论文
共 50 条
  • [41] STUDIES OF THE HER-2/NEU PROTO-ONCOGENE IN HUMAN-BREAST CANCER
    SLAMON, DJ
    GODOLPHIN, W
    ULLRICH, A
    PRESS, MF
    CANCER GENETICS AND CYTOGENETICS, 1989, 41 (02) : 219 - 219
  • [42] HER-2 NEU ONCOGENE EXPRESSION AND DNA PLOIDY ANALYSIS IN BREAST-CANCER
    BACUS, SS
    BACUS, JW
    SLAMON, DJ
    PRESS, MF
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1990, 114 (02) : 164 - 169
  • [43] HER-2/neu diagnostics in breast cancer
    Carney, Walter P.
    Leitzel, Kim
    Ali, Suhail
    Neumann, Rainer
    Lipton, Allan
    BREAST CANCER RESEARCH, 2007, 9 (03)
  • [44] The prognostic value of HER-2/neu oncogene in cervical cancer
    Ndubisi, B
    Sanz, S
    Lu, L
    Podczaski, E
    Benrubi, G
    Masood, S
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1997, 27 (06): : 396 - 401
  • [45] EXPRESSION OF THE HER-2/NEU/C-ERBB-2 ONCOGENE IN BREAST-CANCER
    PRESS, MF
    GODOLPHIN, W
    SLAMON, DJ
    LABORATORY INVESTIGATION, 1989, 60 (01) : A73 - A73
  • [46] Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification
    Lal, P
    Salazar, PA
    Ladanyi, M
    Chen, BY
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2003, 5 (03): : 155 - 159
  • [47] Her-2/neu amplification and breast cancer survival: Results from the Shanghai breast cancer study
    Beeghly-Fadiel, Alicia
    Kataoka, Nobuhiko
    Shu, Xiao-Ou
    Cap, Qiuyin
    Deming, Sandra L.
    Gao, Yu-Tang
    Zheng, Wei
    ONCOLOGY REPORTS, 2008, 19 (05) : 1347 - 1354
  • [48] HER-2 therapy. HER-2/neu diagnostics in breast cancer
    Walter P Carney
    Kim Leitzel
    Suhail Ali
    Rainer Neumann
    Allan Lipton
    Breast Cancer Research, 9
  • [49] Assessment of Her-2/neu gene amplification status in breast carcinoma with equivocal 2+ Her-2/neu immunostaining
    Mostafa, Naglaa A. E.
    Eissa, Saad S.
    Belal, Dalia M.
    Shoman, Soheir H.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2011, 23 (01) : 41 - 46
  • [50] THE RELATIVE PROGNOSTIC-SIGNIFICANCE OF TOTAL CATHEPSIN-D AND HER-2/NEU ONCOGENE AMPLIFICATION IN BREAST-CANCER
    SESHADRI, R
    HORSFALL, DJ
    FIRGAIRA, F
    MCCAUL, K
    SETLUR, V
    CHALMERS, AH
    YEO, R
    INGRAM, D
    DAWKINS, H
    HAHNEL, R
    ALLEN, DM
    BEARD, D
    BRITTENJONES, R
    BLACK, R
    BISWAS, B
    BRIDGEWATER, FHG
    BURKE, AM
    BUTCHER, CJ
    CARRANGIS, H
    CARTER, ML
    COX, JST
    DONOFRIO, GMD
    DEVITT, P
    FLETCHER, I
    GALLERY, R
    GAME, P
    GLYNN, PJ
    GILL, PG
    GUERRIERO, R
    GUE, S
    HAMILTON, DW
    HOFFMANN, CEJ
    HOARE, L
    HUNTER, R
    HUMENIUK, V
    JANSEN, TR
    JOHNSON, R
    JURY, RP
    KING, J
    KING, EPJ
    KIROFF, G
    LANDY, M
    LEONG, P
    MALYCHA, P
    MCINTOSH, NA
    MCLEAY, WRB
    MILL, JCD
    NATAR, G
    NETTLEFORD, J
    NEILD, A
    INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (01) : 61 - 65
12345